Published in J Auton Nerv Syst on February 01, 1989
Sensory innervation of the calvarial bones of the mouse. J Comp Neurol (2009) 1.26
Topography of functional subpopulations of neurons in the superior cervical ganglion of the rat. J Anat (1991) 1.10
CGRP receptor antagonism and migraine. Neurotherapeutics (2010) 0.98
CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment. Br J Clin Pharmacol (2015) 0.93
Inhibition of stimulated meningeal blood flow by a calcitonin gene-related peptide binding mirror-image RNA oligonucleotide. Br J Pharmacol (2006) 0.92
CGRP function-blocking antibodies inhibit neurogenic vasodilatation without affecting heart rate or arterial blood pressure in the rat. Br J Pharmacol (2008) 0.90
Modelling headache and migraine and its pharmacological manipulation. Br J Pharmacol (2014) 0.86
Developmental changes of mast cell populations in the cerebral meninges of the rat. J Anat (2007) 0.83
5-HT(1D) receptor immunoreactivity in the sphenopalatine ganglion: implications for the efficacy of triptans in the treatment of autonomic signs associated with cluster headache. Headache (2011) 0.78
Selective inhibition of trigeminovascular neurons by fremanezumab - a humanized monoclonal anti-CGRP antibody. J Neurosci (2017) 0.75
Cerebral autoregulation. Cerebrovasc Brain Metab Rev (1990) 5.13
Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol (1990) 3.25
Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev (1998) 3.24
The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol (1993) 3.07
Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers. Regul Pept (1984) 2.27
Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels. Acta Physiol Scand (1983) 2.20
Dual role of caspase-11 in mediating activation of caspase-1 and caspase-3 under pathological conditions. J Cell Biol (2000) 2.04
Expression of a dominant negative mutant of interleukin-1 beta converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury. J Exp Med (1997) 1.89
Strain-related differences in susceptibility to transient forebrain ischemia in SV-129 and C57black/6 mice. Stroke (1997) 1.89
Relationship between homocysteine and superoxide dismutase in homocystinuria: possible relevance to cardiovascular risk. Arterioscler Thromb Vasc Biol (2000) 1.86
Ribosome recycling by ribosome recycling factor (RRF)--an important but overlooked step of protein biosynthesis. Adv Biophys (1996) 1.86
Overexpression, solubilization and refolding of a genetically engineered derivative of the penicillin-binding protein 3 of Escherichia coli K12. Mol Microbiol (1988) 1.84
Asymmetric bidirectional replication of Bacillus subtilis chromosome. Nat New Biol (1973) 1.81
Release of histamine from dural mast cells by substance P and calcitonin gene-related peptide. Cephalalgia (1997) 1.78
Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol (1988) 1.77
B cell growth factors and B cell differentiation factor from human T hybridomas. Two distinct kinds of B cell growth factor and their synergism in B cell proliferation. J Exp Med (1983) 1.73
Cloning and nucleotide sequence of the ispA gene responsible for farnesyl diphosphate synthase activity in Escherichia coli. J Biochem (1990) 1.73
Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain (1994) 1.72
Calcitonin gene-related peptide is released from capsaicin-sensitive nerve fibres and induces vasodilatation of human cerebral arteries concomitant with activation of adenylyl cyclase. Cephalalgia (1996) 1.69
Long-term controlled normoglycemia in diabetic non-human primates after transplantation with hCD46 transgenic porcine islets. Am J Transplant (2009) 1.69
Calcitonin gene-related peptide: functional role in cerebrovascular regulation. Proc Natl Acad Sci U S A (1986) 1.65
A molecular chaperone inducer protects neurons from ER stress. Cell Death Differ (2007) 1.63
Ultrasonographic features of recurrent parotitis in childhood. Pediatr Radiol (1994) 1.62
Presumed anticodon structure of glutamic acid tRNA from E. coli: a possible location of a 2-thiouridine derivative in the first position of the anticodon. Biochem Biophys Res Commun (1970) 1.60
The concept of coupling blood flow to brain function: revision required? Ann Neurol (1987) 1.58
Massive large bowel resection decreases bone strength and magnesium content but not calcium content of the femur in rats. Nutrition (2001) 1.53
Pharmacological characterization of adrenergic alpha and beta receptors mediating the vasomotor responses of cerebral arteries in vitro. Circ Res (1974) 1.46
Anomalous left brachiocephalic vein: CT findings. J Comput Assist Tomogr (1992) 1.46
Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels. Br J Pharmacol (1984) 1.46
Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int J Food Microbiol (1998) 1.45
Calcitonin gene-related peptide (CGRP) levels during glyceryl trinitrate (GTN)-induced headache in healthy volunteers. Cephalalgia (2010) 1.45
Toll-like receptor 4 (TLR4), but not TLR3 or TLR9, knock-out mice have neuroprotective effects against focal cerebral ischemia. Neuroscience (2010) 1.43
Pharmacological analysis of 5-hydroxytryptamine receptors in isolated intracranial and extracranial vessels of cat and man. Circ Res (1978) 1.42
Deep white matter lesions on MRI, and not silent brain infarcts are related to headache and dizziness of non-specific cause in non-stroke Japanese subjects. Intern Med (2000) 1.42
Autonomic nerves, mast cells, and amine receptors in human brain vessels. A histochemical and pharmacological study. Brain Res (1976) 1.42
Determination of the cleavage site involved in C-terminal processing of penicillin-binding protein 3 of Escherichia coli. J Bacteriol (1989) 1.40
Genetic and biochemical characterization of a 2-pyrone-4, 6-dicarboxylic acid hydrolase involved in the protocatechuate 4, 5-cleavage pathway of Sphingomonas paucimobilis SYK-6. J Bacteriol (1999) 1.38
Mechanisms of reduced striatal NMDA excitotoxicity in type I nitric oxide synthase knock-out mice. J Neurosci (1997) 1.38
Molecular dimensions of Hb-based O(2) carriers determine constriction of resistance arteries and hypertension. Am J Physiol Heart Circ Physiol (2000) 1.37
Location of fatty acids in lipid A obtained from lipopolysaccharide of Rhodopseudomonas sphaeroides ATCC 17023. J Biol Chem (1988) 1.36
Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action. J Pharmacol Exp Ther (1985) 1.34
Murine hemopoietic colonies in culture containing normoblasts, macrophages, and megakaryocytes. Am J Hematol (1978) 1.32
Impact of thrombocytopenia on survival of baboons with genetically modified pig liver transplants: clinical relevance. Am J Transplant (2009) 1.29
Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic adenosine monophosphate accumulation or release of an endothelium-derived relaxing factor in the cat. Neurosci Lett (1985) 1.29
Nucleic acid duplex stability: influence of base composition on cation effects. Nucleic Acids Res (1999) 1.29
Endoscopic gastric submucosal transplantation of islets (ENDO-STI): technique and initial results in diabetic pigs. Am J Transplant (2009) 1.27
Immunohistochemical localization of a vasodilatory polypeptide (VIP) in cerebrovascular nerves. Brain Res (1976) 1.27
Correlation between wave components of the second derivative of plethysmogram and arterial distensibility. Jpn Heart J (1998) 1.27
ACh dilates pial arterioles in endothelial and neuronal NOS knockout mice by NO-dependent mechanisms. Am J Physiol (1996) 1.26
Frequencies of CYP2D6 mutant alleles in a normal Japanese population and metabolic activity of dextromethorphan O-demethylation in different CYP2D6 genotypes. Br J Clin Pharmacol (2000) 1.25
The stable pyrimidines UDPbetaS and UTPgammaS discriminate between the P2 receptors that mediate vascular contraction and relaxation of the rat mesenteric artery. Br J Pharmacol (2000) 1.23
Erthropoietic precursors in mice with phenylhydrazine-induced anemia. Am J Hematol (1976) 1.23
Engineering and overexpression of periplasmic forms of the penicillin-binding protein 3 of Escherichia coli. Biochem J (1994) 1.23
Calcitonin gene-related peptide (CGRP): perivascular distribution and vasodilatory effects. Regul Pept (1986) 1.22
Substance P: immunohistochemical localization and effect upon cat pial arteries in vitro and in situ. J Physiol (1981) 1.22
Amine mechanisms in the cerebral circulation. Pharmacol Rev (1976) 1.21
Recipient tissue factor expression is associated with consumptive coagulopathy in pig-to-primate kidney xenotransplantation. Am J Transplant (2010) 1.21
Thin-section CT findings in rheumatoid arthritis-associated lung disease: CT patterns and their courses. J Comput Assist Tomogr (1999) 1.20
Generation of triplet and cation-radical bacteriochlorophyll a in carotenoidless LH1 and LH2 antenna complexes from Rhodobacter sphaeroides. Biochemistry (1998) 1.20
Neurogenic mechanisms in the cerebrovascular bed. Autonomic nerves, amine receptors and their effects on cerebral blood flow. Acta Physiol Scand Suppl (1975) 1.19
Differential functionalities of amphiphilic peptide segments of the cell-septation penicillin-binding protein 3 of Escherichia coli. Mol Microbiol (2000) 1.19
Metabolic aspects of pig-to-monkey (Macaca fascicularis) islet transplantation: implications for translation into clinical practice. Diabetologia (2007) 1.19
Activation of hepatocyte growth factor by proteolytic conversion of a single chain form to a heterodimer. J Biol Chem (1992) 1.17
Neuropeptide Y: cerebrovascular innervation and vasomotor effects in the cat. Neurosci Lett (1983) 1.17
The peptidergic innervation of the human superficial temporal artery: immunohistochemistry, ultrastructure, and vasomotility. Peptides (1995) 1.17
Lipid modification of Escherichia coli penicillin-binding protein 3. J Bacteriol (1988) 1.16
Osmoregulation of the fatty acid receptor gene fadL in Escherichia coli. Mol Gen Genet (1993) 1.15
Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion. Neuroscience (2010) 1.15
Neuropeptide Y is a potent inhibitor of cyclic AMP accumulation in feline cerebral blood vessels. Acta Physiol Scand (1985) 1.15
Effects of an ET1-receptor antagonist, FR139317, on regional haemodynamic responses to endothelin-1 and [Ala11,15]Ac-endothelin-1 (6-21) in conscious rats. Br J Pharmacol (1994) 1.15
Contribution of the Pmra promoter to expression of genes in the Escherichia coli mra cluster of cell envelope biosynthesis and cell division genes. J Bacteriol (1998) 1.15
CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation. Pharmacogenomics J (2006) 1.14
4-Thiouridine-specific spin-labeling of E. coli transfer RNA. Biochem Biophys Res Commun (1970) 1.13
A temporal model of animal behavior based on a fractality in the feeding of Drosophila melanogaster. Biol Cybern (1993) 1.13
Probucol prevents lipid storage in macrophages. Atherosclerosis (1986) 1.13
Usefulness of ceramic implants in neurosurgery. Neurosurgery (1987) 1.13
Selective inhibition of thrombin by (2R,4R)-4-methyl-1-[N2-[(3-methyl-1,2,3,4-tetrahydro-8-quinolinyl++ +) sulfonyl]-l-arginyl)]-2-piperidinecarboxylic acid. Biochemistry (1984) 1.12
A novel glycan polymerase that synthesizes uncross-linked peptidoglycan in Escherichia coli. FEBS Lett (1984) 1.11
Circulating erythropoietic precursors assessed in culture: characterization in normal men and patients with hemoglobinopathies. Blood (1977) 1.11
Mitogenic effects of ATP on vascular smooth muscle cells vs. other growth factors and sympathetic cotransmitters. Am J Physiol (1993) 1.11
Interleukin-1beta mediates ischemic injury in the rat retina. Exp Eye Res (2001) 1.10
Binding of penicillin to thiol-penicillin-binding protein 3 of Escherichia coli: identification of its active site. Mol Gen Genet (1985) 1.10
Neuronal messengers in the human cerebral circulation. Peptides (2001) 1.10
Development of selective IgM deficiency in systemic lupus erythematosus patients with disease of long duration. Arthritis Rheum (1987) 1.10
pH and cation effects on the properties of parallel pyrimidine motif DNA triplexes. Biochemistry (2001) 1.09
5-HT(1B) and 5-HT(1D) receptors in the human trigeminal ganglion: co-localization with calcitonin gene-related peptide, substance P and nitric oxide synthase. Brain Res (2001) 1.09
Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques. Eur J Pharmacol (1999) 1.09
VIP (vasoactive intestinal polypeptide)-containing nerves of intracranial arteries in mammals. Cell Tissue Res (1980) 1.08
Potent inhibition of thrombin by the newly synthesized arginine derivative No. 805. The importance of stereo-structure of its hydrophobic carboxamide portion. Biochem Biophys Res Commun (1981) 1.08
Parental perception of behavioral symptoms in Japanese autistic children. J Autism Dev Disord (1987) 1.08
Sumatriptan is a potent vasoconstrictor of human dural arteries via a 5-HT1-like receptor. Cephalalgia (1992) 1.07
Genetic and biochemical characterization of 4-carboxy-2-hydroxymuconate-6-semialdehyde dehydrogenase and its role in the protocatechuate 4,5-cleavage pathway in Sphingomonas paucimobilis SYK-6. J Bacteriol (2000) 1.07
Induction of BiP, an ER-resident protein, prevents the neuronal death induced by transient forebrain ischemia in gerbil. Brain Res (2008) 1.07
Peptide-containing nerve fibers in human cerebral arteries: immunocytochemistry, radioimmunoassay, and in vitro pharmacology. Ann Neurol (1987) 1.07
A pharmacologic comparison of histamine receptors in isolated extracranial and intracranial arteries in vitro. Neurology (1975) 1.07
Neuropeptide Y-like immunoreactivity in perivascular nerve fibres of the guinea-pig. Regul Pept (1985) 1.07
Cutaneous vascular reactivity is reduced in aging and in heart failure: association with inflammation. Clin Sci (Lond) (2003) 1.07
Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P. Neurosci Lett (1985) 1.07
On the pathogenesis of regional cerebral ischemia in intracranial hemorrhage: a causal influence of potassium? Pediatr Res (1986) 1.07
Immunohistochemical identification of Ito cells and their myofibroblastic transformation in adult human liver. Virchows Arch (1994) 1.06